Funding Rounds
Step Pharma Series A (2017, $15M)
Step PharmaManufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).
Summary
Stage: Series A
Raised Amount: $15.80M
Stage: Series A
Raised Amount: $15.80M
